cgp 39551 has been researched along with pentylenetetrazole in 3 studies
| Studies (cgp 39551) | Trials (cgp 39551) | Recent Studies (post-2010) (cgp 39551) | Studies (pentylenetetrazole) | Trials (pentylenetetrazole) | Recent Studies (post-2010) (pentylenetetrazole) |
|---|---|---|---|---|---|
| 75 | 0 | 4 | 6,737 | 30 | 1,496 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allgeier, H; Fagg, GE; Heckendorn, R; Jeker, A; Klebs, K; Olpe, HR; Portet, C; Schmutz, M; van Riezen, H; Vassout, A | 1 |
| Mares, P; Vachová, D; VelĂsek, L | 1 |
| Dunworth, SJ; Stephens, DN | 1 |
3 other study(ies) available for cgp 39551 and pentylenetetrazole
| Article | Year |
|---|---|
The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Electroshock; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; Pentylenetetrazole; Postural Balance; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1990 |
Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effects of CGP 39551.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Convulsants; Drug Evaluation, Preclinical; Epilepsy, Tonic-Clonic; Excitatory Amino Acid Antagonists; Male; Pentylenetetrazole; Rats; Rats, Wistar | 1997 |
Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Convulsants; Diazepam; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome; Synaptic Transmission | 1998 |